The Trip Treatment (The New Yorker)
techstepgenr8tion
Veteran
![User avatar](./download/file.php?avatar=1213.jpg)
Joined: 6 Feb 2005
Age: 45
Gender: Male
Posts: 24,529
Location: 28th Path of Tzaddi
I just had the chance to read this and wow, it's a long article but it's well worth the read from start to finish.
It starts with recounting the success of recent double-blind pilot studies into the usefulness of psilocybin in palliative care such as for terminal cancer patients and very quickly moves across the board to other topics such as alternative uses such as addiction and long term depression and anxiety, the history of the research, the FDA's slow reopening of research, the reasons it was shut down in the early 1970's, and also some of what other drugs like LSD have showed to be happening on fMRI.
http://www.newyorker.com/magazine/2015/ ... -treatment
One of the paragraphs that had a lot of truth from my own past experience:
A substance that allowed such cross-talk seems to have a lot of potential for boosting innovation in a whole variety of directions as well. I'd add to this article another angle on that account that didn't get addressed - corporate R&D meetings
![Razz :P](./images/smilies/icon_razz.gif)
_________________
The loneliest part of life: it's not just that no one is on your cloud, few can even see your cloud.
Similar Topics | |
---|---|
SCOTUS skeptical-Challenge to Tennessee trans treatment ban |
04 Dec 2024, 5:03 pm |